Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting
Abstract The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formu...
Gespeichert in:
Veröffentlicht in: | Vaccine 2007-03, Vol.25 (14), p.2634-2642 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2642 |
---|---|
container_issue | 14 |
container_start_page | 2634 |
container_title | Vaccine |
container_volume | 25 |
creator | Forsyth, Kevin D Wirsing von Konig, Carl-Heinz Tan, Tina Caro, Jaime Plotkin, Stanley |
description | Abstract The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formulation, in 2002, of the following recommendation: all countries should consider expanding existing vaccination strategies to include adding pertussis booster doses to pre-school children (4–6 years old), to adolescents, and to those specific adults that have the highest risk of transmitting Bordetella pertussis infection to vulnerable infants. The GPI met again in 2005, where it reinforced its previous recommendation for universal adolescent immunization. Additionally, the GPI recommended implementation of the cocoon strategy (immunization of family members and close contacts of the newborn) in countries where it is economically feasible, and encouraged efforts toward global standardization of pertussis disease clinical definitions and diagnostics. Universal adult vaccination is a logical goal for the ultimate elimination of pertussis disease, but feasibility issues remain obstacles to implementation. |
doi_str_mv | 10.1016/j.vaccine.2006.12.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70288580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X06013478</els_id><sourcerecordid>20303443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-a31d0fa35f30bd48278e8397f0819a353afc837f3c2d29f1e8b4b8fdd9897d523</originalsourceid><addsrcrecordid>eNqFkl9rFDEUxQdRbK1-BCUg-rbrTTIzyfhQkaK1ULD4B3wLmeRGs84kazKz0G9vxl1Z6EufAsnvnHtvzq2q5xTWFGj7ZrPeaWN8wDUDaNeUrYGKB9UplYKvWEPlw-oUWFuvago_TqonOW8AoOG0e1ydUMEkiLo5reJNwh2GycdAoiNbTNOcs89vyRc0cRwxWL08ZmIx-R1a4lIcyfQLSS5AsORyiL0eyM1_JbkKfvJFtEOS4hzspPsByYg4-fDzafXI6SHjs8N5Vn3_-OHbxafV9efLq4v31yvTgJhWmlMLTvPGcehtLZmQKHknHEjalWuunZFcOG6YZZ2jKPu6l87aTnbCNoyfVa_3vtsU_8yYJzX6bHAYdMA4ZyWASdlIuBdkwIHXNS_gyzvgJs4plCEUbWpB26apl7rNnjIp5pzQqW3yo063ioJaglMbdQhOLcEpylQJruheHNznfkR7VB2SKsCrA6Cz0YNLOhifj5xsS9j_uHd7Dsvv7jwmlY3HYND6hGZSNvp7Wzm_42AGH3wp-htvMR-nVrkI1Ndly5YlgxYor4XkfwGosM8m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547165542</pqid></control><display><type>article</type><title>Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Forsyth, Kevin D ; Wirsing von Konig, Carl-Heinz ; Tan, Tina ; Caro, Jaime ; Plotkin, Stanley</creator><creatorcontrib>Forsyth, Kevin D ; Wirsing von Konig, Carl-Heinz ; Tan, Tina ; Caro, Jaime ; Plotkin, Stanley</creatorcontrib><description>Abstract The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formulation, in 2002, of the following recommendation: all countries should consider expanding existing vaccination strategies to include adding pertussis booster doses to pre-school children (4–6 years old), to adolescents, and to those specific adults that have the highest risk of transmitting Bordetella pertussis infection to vulnerable infants. The GPI met again in 2005, where it reinforced its previous recommendation for universal adolescent immunization. Additionally, the GPI recommended implementation of the cocoon strategy (immunization of family members and close contacts of the newborn) in countries where it is economically feasible, and encouraged efforts toward global standardization of pertussis disease clinical definitions and diagnostics. Universal adult vaccination is a logical goal for the ultimate elimination of pertussis disease, but feasibility issues remain obstacles to implementation.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2006.12.017</identifier><identifier>PMID: 17280745</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adolescents ; Adult ; Adults ; Allergy and Immunology ; Applied microbiology ; Bacterial diseases ; Bacterial Typing Techniques ; Biological and medical sciences ; Bordetella pertussis ; Bordetella pertussis - classification ; Child, Preschool ; Diagnosis, Differential ; Ent and stomatologic bacterial diseases ; Epidemiology ; Fundamental and applied biological sciences. Psychology ; Health economics ; Human bacterial diseases ; Humans ; Immunization ; Immunization strategies ; Infants ; Infection ; Infectious diseases ; Medical sciences ; Microbiology ; Pertussis ; Reporting ; Teenagers ; Transmission ; Vaccination - economics ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Whooping cough ; Whooping Cough - epidemiology ; Whooping Cough - prevention & control</subject><ispartof>Vaccine, 2007-03, Vol.25 (14), p.2634-2642</ispartof><rights>Elsevier Ltd</rights><rights>2006 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Mar 30, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-a31d0fa35f30bd48278e8397f0819a353afc837f3c2d29f1e8b4b8fdd9897d523</citedby><cites>FETCH-LOGICAL-c507t-a31d0fa35f30bd48278e8397f0819a353afc837f3c2d29f1e8b4b8fdd9897d523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1547165542?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974,64362,64364,64366,72216</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18626445$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17280745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Forsyth, Kevin D</creatorcontrib><creatorcontrib>Wirsing von Konig, Carl-Heinz</creatorcontrib><creatorcontrib>Tan, Tina</creatorcontrib><creatorcontrib>Caro, Jaime</creatorcontrib><creatorcontrib>Plotkin, Stanley</creatorcontrib><title>Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formulation, in 2002, of the following recommendation: all countries should consider expanding existing vaccination strategies to include adding pertussis booster doses to pre-school children (4–6 years old), to adolescents, and to those specific adults that have the highest risk of transmitting Bordetella pertussis infection to vulnerable infants. The GPI met again in 2005, where it reinforced its previous recommendation for universal adolescent immunization. Additionally, the GPI recommended implementation of the cocoon strategy (immunization of family members and close contacts of the newborn) in countries where it is economically feasible, and encouraged efforts toward global standardization of pertussis disease clinical definitions and diagnostics. Universal adult vaccination is a logical goal for the ultimate elimination of pertussis disease, but feasibility issues remain obstacles to implementation.</description><subject>Adolescent</subject><subject>Adolescents</subject><subject>Adult</subject><subject>Adults</subject><subject>Allergy and Immunology</subject><subject>Applied microbiology</subject><subject>Bacterial diseases</subject><subject>Bacterial Typing Techniques</subject><subject>Biological and medical sciences</subject><subject>Bordetella pertussis</subject><subject>Bordetella pertussis - classification</subject><subject>Child, Preschool</subject><subject>Diagnosis, Differential</subject><subject>Ent and stomatologic bacterial diseases</subject><subject>Epidemiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Health economics</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization strategies</subject><subject>Infants</subject><subject>Infection</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Pertussis</subject><subject>Reporting</subject><subject>Teenagers</subject><subject>Transmission</subject><subject>Vaccination - economics</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Whooping cough</subject><subject>Whooping Cough - epidemiology</subject><subject>Whooping Cough - prevention & control</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkl9rFDEUxQdRbK1-BCUg-rbrTTIzyfhQkaK1ULD4B3wLmeRGs84kazKz0G9vxl1Z6EufAsnvnHtvzq2q5xTWFGj7ZrPeaWN8wDUDaNeUrYGKB9UplYKvWEPlw-oUWFuvago_TqonOW8AoOG0e1ydUMEkiLo5reJNwh2GycdAoiNbTNOcs89vyRc0cRwxWL08ZmIx-R1a4lIcyfQLSS5AsORyiL0eyM1_JbkKfvJFtEOS4hzspPsByYg4-fDzafXI6SHjs8N5Vn3_-OHbxafV9efLq4v31yvTgJhWmlMLTvPGcehtLZmQKHknHEjalWuunZFcOG6YZZ2jKPu6l87aTnbCNoyfVa_3vtsU_8yYJzX6bHAYdMA4ZyWASdlIuBdkwIHXNS_gyzvgJs4plCEUbWpB26apl7rNnjIp5pzQqW3yo063ioJaglMbdQhOLcEpylQJruheHNznfkR7VB2SKsCrA6Cz0YNLOhifj5xsS9j_uHd7Dsvv7jwmlY3HYND6hGZSNvp7Wzm_42AGH3wp-htvMR-nVrkI1Ndly5YlgxYor4XkfwGosM8m</recordid><startdate>20070330</startdate><enddate>20070330</enddate><creator>Forsyth, Kevin D</creator><creator>Wirsing von Konig, Carl-Heinz</creator><creator>Tan, Tina</creator><creator>Caro, Jaime</creator><creator>Plotkin, Stanley</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070330</creationdate><title>Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting</title><author>Forsyth, Kevin D ; Wirsing von Konig, Carl-Heinz ; Tan, Tina ; Caro, Jaime ; Plotkin, Stanley</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-a31d0fa35f30bd48278e8397f0819a353afc837f3c2d29f1e8b4b8fdd9897d523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adolescents</topic><topic>Adult</topic><topic>Adults</topic><topic>Allergy and Immunology</topic><topic>Applied microbiology</topic><topic>Bacterial diseases</topic><topic>Bacterial Typing Techniques</topic><topic>Biological and medical sciences</topic><topic>Bordetella pertussis</topic><topic>Bordetella pertussis - classification</topic><topic>Child, Preschool</topic><topic>Diagnosis, Differential</topic><topic>Ent and stomatologic bacterial diseases</topic><topic>Epidemiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Health economics</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization strategies</topic><topic>Infants</topic><topic>Infection</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Pertussis</topic><topic>Reporting</topic><topic>Teenagers</topic><topic>Transmission</topic><topic>Vaccination - economics</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Whooping cough</topic><topic>Whooping Cough - epidemiology</topic><topic>Whooping Cough - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Forsyth, Kevin D</creatorcontrib><creatorcontrib>Wirsing von Konig, Carl-Heinz</creatorcontrib><creatorcontrib>Tan, Tina</creatorcontrib><creatorcontrib>Caro, Jaime</creatorcontrib><creatorcontrib>Plotkin, Stanley</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Forsyth, Kevin D</au><au>Wirsing von Konig, Carl-Heinz</au><au>Tan, Tina</au><au>Caro, Jaime</au><au>Plotkin, Stanley</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-03-30</date><risdate>2007</risdate><volume>25</volume><issue>14</issue><spage>2634</spage><epage>2642</epage><pages>2634-2642</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract The Global Pertussis Initiative (GPI) was established in 2001 to assess the global extent of the ongoing problem of pertussis and to evaluate and prioritize pertussis control strategies. Exchange of data, knowledge, and experience, facilitated by discussion and debate, resulted in the formulation, in 2002, of the following recommendation: all countries should consider expanding existing vaccination strategies to include adding pertussis booster doses to pre-school children (4–6 years old), to adolescents, and to those specific adults that have the highest risk of transmitting Bordetella pertussis infection to vulnerable infants. The GPI met again in 2005, where it reinforced its previous recommendation for universal adolescent immunization. Additionally, the GPI recommended implementation of the cocoon strategy (immunization of family members and close contacts of the newborn) in countries where it is economically feasible, and encouraged efforts toward global standardization of pertussis disease clinical definitions and diagnostics. Universal adult vaccination is a logical goal for the ultimate elimination of pertussis disease, but feasibility issues remain obstacles to implementation.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17280745</pmid><doi>10.1016/j.vaccine.2006.12.017</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2007-03, Vol.25 (14), p.2634-2642 |
issn | 0264-410X 1873-2518 |
language | eng |
recordid | cdi_proquest_miscellaneous_70288580 |
source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
subjects | Adolescent Adolescents Adult Adults Allergy and Immunology Applied microbiology Bacterial diseases Bacterial Typing Techniques Biological and medical sciences Bordetella pertussis Bordetella pertussis - classification Child, Preschool Diagnosis, Differential Ent and stomatologic bacterial diseases Epidemiology Fundamental and applied biological sciences. Psychology Health economics Human bacterial diseases Humans Immunization Immunization strategies Infants Infection Infectious diseases Medical sciences Microbiology Pertussis Reporting Teenagers Transmission Vaccination - economics Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Whooping cough Whooping Cough - epidemiology Whooping Cough - prevention & control |
title | Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T19%3A45%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevention%20of%20pertussis:%20Recommendations%20derived%20from%20the%20second%20Global%20Pertussis%20Initiative%20roundtable%20meeting&rft.jtitle=Vaccine&rft.au=Forsyth,%20Kevin%20D&rft.date=2007-03-30&rft.volume=25&rft.issue=14&rft.spage=2634&rft.epage=2642&rft.pages=2634-2642&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2006.12.017&rft_dat=%3Cproquest_cross%3E20303443%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547165542&rft_id=info:pmid/17280745&rft_els_id=1_s2_0_S0264410X06013478&rfr_iscdi=true |